In other countries
The same active substances on other registers, the same brand first.
- SandostatinBrazil · Novartis Biociencias S.ASame brand
- SANDOSTATIN 100 microgramos/ml SOLUCION INYECTABLE Y PARA PERFUSIONSpain · 0,1 mg · solución inyectable y para perfusión · Novartis Farmaceutica S.A.Same brand
- SANDOSTATIN 50 microgramos/ml SOLUCION INYECTABLE Y PARA PERFUSIONSpain · 0,05 mg · solución inyectable y para perfusión · Novartis Farmaceutica S.A.Same brand
- SANDOSTATIN LAR 10 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLESpain · 11,2 mg · polvo y disolvente para suspensión inyectable · Novartis Farmaceutica S.A.Same brand
- Sandostatin 0,1 mg/ml otopina za injekciju/infuzijuCroatia · otopina za injekciju/infuziju · Novartis Hrvatska d.o.o., Radnička cesta 37b, Zagreb, HrvatskaSame brand
- Sandostatin 0,5 mg/ml otopina za injekciju/infuzijuCroatia · otopina za injekciju/infuziju · Novartis Hrvatska d.o.o., Radnička cesta 37b, Zagreb, HrvatskaSame brand
- Sandostatin LAR 20 mg prašak i otapalo za suspenziju za injekcijuCroatia · prašak i otapalo za suspenziju za injekciju · Novartis Hrvatska d.o.o., Radnička cesta 37b, Zagreb, HrvatskaSame brand
- SANDOSTATIN 100 micrograme/mlRomania · 0,1mg/ml · sol. inj./perf. · Novartis Pharma GMBHSame brand
- SANDOSTATIN LAR 10 mgRomania · 10mg · pulb. si solv. pt. susp. inj. · Novartis Pharma GMBHSame brand
- SANDOSTATIN LAR 20 mgRomania · 20mg · pulb. si solv. pt. susp. inj. · Novartis Pharma GMBHSame brand
- Sandostatin®Serbia · 0.1mg/mL · rastvor za injekciju/infuziju · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand
- Sandostatin®Serbia · 0.1mg/mL · rastvor za injekciju/infuziju · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand
- Sandostatin®Serbia · 0.1mg/mL · rastvor za injekciju/infuziju · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand
- Sandostatin 0.05MG-ML AmpSaudi Arabia · NovartisSame brand
- Sandostatin 0.1MG-ML AmpSaudi Arabia · NovartisSame brand
- Sandostatin 0.2MG-ML 5ML AmpSaudi Arabia · NovartisSame brand
- SANDOSTATIN LAR FOR INJECTION 20 mgSingapore · 20 mg/vial · injection · Novartis (Singapore) Pte LTDSame brand
- SANDOSTATIN LAR FOR INJECTION 30 mgSingapore · 30 mg/vial · injection · Novartis (Singapore) Pte LTDSame brand
- SANDOSTATIN INJECTION 0.1 mg/mlSingapore · 0.1 mg/ml · injection · Novartis (Singapore) Pte LTDSame brand
- Sandostatin LarUnited States · 10MG BASE/VIAL, 20MG BASE/VIAL, 30MG BASE/VIAL · injectable · NovartisSame brand
- SandostatinUnited States · 0.05MG BASE/ML, 0.1MG BASE/ML, 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … · injectable · NovartisSame brand
- acetato de octreotidaBrazil · Cristália Produtos Químicos Farmacêuticos Ltda.Same substance
- OctrideBrazil · Sun Farmacêutica do Brasil LtdaSame substance
- OczyesaEuropean Union · Camurus ABSame substance
- MycapssaEuropean Union · Amryt Pharmaceuticals DACSame substance
- Octreotide Bioindustria L.I.M.Italy · Concentrato per soluzione per infusione · Bioindustria Laboratorio Italiano Medicinali S.P.A.Same substance
- Octreotide SunItaly · Soluzione iniettabile · Sun Pharmaceutical Industries (Europe) B.V.Same substance
- Octreotide TevaItaly · Polvere e solvente per sospensione iniettabile a rilascio prolungato · Teva B.V.Same substance
- Octreotide Bendalis 0,05 mg/ml, oplossing voor injectieNetherlands · Oplossing voor injectie · Bendalis GmbHSame substance
- Octreotide Bendalis 0,1 mg/ml, oplossing voor injectieNetherlands · Oplossing voor injectie · Bendalis GmbHSame substance
- Octreotide Bendalis 0,2 mg/ml, oplossing voor injectieNetherlands · Oplossing voor injectie · Bendalis GmbHSame substance
- Max HealthNew Zealand · Inj 50 mcg per ml, 1 ml ampouleSame substance
- Max HealthNew Zealand · Inj 500 mcg per ml, 1 ml ampouleSame substance
- Max HealthNew Zealand · Inj 100 mcg per ml, 1 ml ampouleSame substance
- Octreotide AcetateUnited States · 0.05MG BASE/ML, 0.1MG BASE/ML, 0.2MG BASE/ML … · injectable · Sun Pharm IndsSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Octreotide
- Strength
- 30 MG / VIAL
- Dosage form
- Powder For Suspension (Sustained-Release
- Route
- Intramuscular
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 27 Jan 1999
- Registration
- DIN 02239325
- Marketing authorisation holder
- Novartis Pharmaceuticals Canada INC
- ATC code
- H01CB02
- Supply
- PRESCRIPTION